Literature DB >> 18680274

Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.

Gianfranco Balboni1, Stella Fiorini, Anna Baldisserotto, Claudio Trapella, Yusuke Sasaki, Akihiro Ambo, Ewa D Marczak, Lawrence H Lazarus, Severo Salvadori.   

Abstract

Some reference opioids containing the Dmt-Tic pharmacophore, especially the delta agonists H-Dmt-Tic-Gly-NH-Ph (1) and H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid (4) (UFP-512) were evaluated for the influence of the substitution of Gly with aspartic acid, its chirality, and the importance of the -NH-Ph and N(1)H-Bid hydrogens in the inductions of delta agonism. The results provide the following conclusions: (i) Asp increases delta selectivity by lowering the mu affinity; (ii) -NH-Ph and N(1)H-Bid nitrogens methylation transforms the delta agonists into delta antagonists; (iii) the substitution of Gly with L-Asp/D-Asp in the delta agonist H-Dmt-Tic-Gly-NH-Ph gave delta antagonists; the same substitution in the delta agonist H-Dmt-Tic-NH-CH2-Bid yielded more selective agonists, H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid and H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid; (iv) L-Asp seems important only in functional bioactivity, not in receptor affinity; (v) H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid(N(1)-Me) (10) evidenced analgesia similar to 4, which was reversed by naltrindole only in the tail flick. 4 and 10 had opposite behaviours in mice; 4 caused agitation, 10 gave sedation and convulsions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680274      PMCID: PMC2812024          DOI: 10.1021/jm800587e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  49 in total

Review 1.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

2.  Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.

Authors:  Raffaella Vergura; Elena Valenti; Christopher P Hebbes; Elaine C Gavioli; Barbara Spagnolo; John McDonald; David G Lambert; Gianfranco Balboni; Severo Salvadori; Domenico Regoli; Girolamo Calo'
Journal:  Peptides       Date:  2006-09-11       Impact factor: 3.750

3.  Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.

Authors:  Gianfranco Balboni; Severo Salvadori; Remo Guerrini; Lucia Negri; Elisa Giannini; Yunden Jinsmaa; Sharon D Bryant; Lawrence H Lazarus
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

4.  Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity.

Authors:  Yusuke Sasaki; Ai Sasaki; Hideko Niizuma; Harumi Goto; Akihiro Ambo
Journal:  Bioorg Med Chem       Date:  2003-03-06       Impact factor: 3.641

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  The expression of delta- and kappa-opioid receptor is enhanced during intestinal inflammation in mice.

Authors:  Olga Pol; José R Palacio; Margarita M Puig
Journal:  J Pharmacol Exp Ther       Date:  2003-04-30       Impact factor: 4.030

7.  Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Ravil Petrov; Chad K Park; Shou-wu Ma; Peg Davis; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  J Med Chem       Date:  2007-10-10       Impact factor: 7.446

8.  Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.

Authors:  Raffaella Vergura; Gianfranco Balboni; Barbara Spagnolo; Elaine Gavioli; David G Lambert; John McDonald; Claudio Trapella; Lawrence H Lazarus; Domenico Regoli; Remo Guerrini; Severo Salvadori; Girolamo Caló
Journal:  Peptides       Date:  2007-10-23       Impact factor: 3.750

9.  Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice.

Authors:  Xu Dai; Shi-gang Cui; Shi-rong Li; Qiang Chen; Rui Wang
Journal:  Behav Brain Res       Date:  2007-05-01       Impact factor: 3.332

10.  Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

Authors:  Yasuko Koda; Mark Del Borgo; Susanne T Wessling; Lawrence H Lazarus; Yoshio Okada; Istvan Toth; Joanne T Blanchfield
Journal:  Bioorg Med Chem       Date:  2008-04-15       Impact factor: 3.641

View more
  6 in total

1.  Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Engin Bojnik; Anna Borsodi; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  Mol Divers       Date:  2012-11-04       Impact factor: 2.943

2.  Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show in Vitro Kappa and Mu Opioid Receptor Agonism.

Authors:  Deanna Montgomery; Jessica P Anand; Nicholas W Griggs; Thomas J Fernandez; Joshua G Hartman; Ashley A Sánchez-Santiago; Irina D Pogozheva; John R Traynor; Henry I Mosberg
Journal:  ACS Chem Neurosci       Date:  2019-07-01       Impact factor: 4.418

3.  Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.

Authors:  Steven Ballet; Ewa D Marczak; Debby Feytens; Severo Salvadori; Yusuke Sasaki; Andrew D Abell; Lawrence H Lazarus; Gianfranco Balboni; Dirk Tourwé
Journal:  Bioorg Med Chem Lett       Date:  2010-01-20       Impact factor: 2.823

4.  Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds.

Authors:  Gianfranco Balboni; Erika Marzola; Yusuke Sasaki; Akihiro Ambo; Ewa D Marczak; Lawrence H Lazarus; Severo Salvadori
Journal:  Bioorg Med Chem       Date:  2010-06-25       Impact factor: 3.641

5.  A DFT and semiempirical model-based study of opioid receptor affinity and selectivity in a group of molecules with a morphine structural core.

Authors:  Tamara Bruna-Larenas; Juan S Gómez-Jeria
Journal:  Int J Med Chem       Date:  2012-12-13

6.  Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour.

Authors:  Alok K Paul; Krystel L Woolley; Mohammed Rahmatullah; Polrat Wilairatana; Jason A Smith; Nuri Gueven; Nikolas Dietis
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.